ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Biocon Biologics, Viatris get EC approval for biosimilar Bevacizumab expresspharma
April 27, 2021Abevmy 100 and 400 mg is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen. -
Biocon Biologics and Viatris get CHMP Nod for Abevmy expresspharma
March 01, 2021Biocon Biologics, a subsidiary of Biocon announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authoris ation of their biosimilar Bevacizumab ...
Pharma Sources Insight January 2025
